In medical communications, quality isn’t a final checkbox – it’s built into every stage of the process. We hold ourselves to the highest standards of scientific integrity and publishing ethics, because the work we produce has real implications for clinical practice, patient care, and the integrity of the scientific record.
We utilize relevant related guidance, including clinical trial guidelines for informed consent (Declaration of Helsinki), conduct of trials (ICH-GCP), and reporting (FDA registration & reporting requirements).
All our projects undergo review by the scientific director and/or a second medical writer at each stage of development, to review for clarity, cohesion, inclusion of key messages and critical references, and scientific rigor.
Author and stakeholder feedback is gathered at each stage and compiled transparently for everyone’s review. We ensure our participation in public-facing projects is always clearly disclosed, including the financial support for the project.
